Xalles Holdings Inc. (OTC: XALL) is proud to announce a strategic partnership between its subsidiaries, InnovationsHR and Capital Innovations Management, with Ovation Health, a premier national health plan provider renowned for offering superior benefits at lower costs. This collaboration aims to transform the employer health plan landscape, empowering businesses to control their health benefits and achieve substantial savings without annual rate increases.
About Ovation Health: Quality Care at Fair Rates
Ovation Health stands out for its affordable, comprehensive health plans covering full medical, dental, and vision care. What sets Ovation Health apart is its founding by physicians who have intricately designed health plans focusing on quality care at affordable rates. The program achieves cost reductions through the innovative use of telemedicine, an extensive pharmacy program, and a growing network of physicians, facilitated by fixed-rate direct contracting and broader provider network relationships.
Ovation Health's Offerings Include:
- An Open Network: Members can continue with their existing local providers or choose new ones.
- A National Telemedicine Network: Ensures quick access to medical care across urban and rural areas.
- Zero Copays: For primary care, labs, and imaging for all group plan members.
- A Care Team: Offers personalized healthcare coordination and patient advocacy.
- A Robust Pharmacy Program: Provides medications at cost, reducing expenses.
- Customized Plan Options: A wide range of specialized health benefits from various provider partners.
Discover more about how Ovation Health is leading the charge in affordable healthcare solutions by visiting https://ovation.health/.
Additionally, gain insights into the health insurance industry with Dr. John McCormick on the "Pulse of Healthcare" podcast, available at https://thepulseofhealthcare.com/.
About Xalles Holdings Inc. (OTC Pink: XALL)
Xalles Holdings Inc. is a leading holding company, specializing in innovative technology and financial service solutions. Focused on growth and diversification, Xalles Holdings is committed to developing cutting-edge technology-based solutions across various sectors, with an emphasis on supporting disruptive companies. Utilizing its proprietary Xalles RISE Business Model (Roll In, Selected Exit), the company actively seeks acquisition targets with solid management teams, robust business models, expansive total attainable markets (TAM), and enticing exit opportunities. Emphasizing the integration of blockchain and cutting-edge technologies, Xalles provides industry-leading solutions, poised to capture recurring revenue streams over time. Discover more at Xalles.com.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at SEC.gov and in OTC Markets at OTCMarkets.com.
Investor Relations Contact:
IR: 202.779.1460